Peregrine Pharma (PPHM) Tops Q4 EPS by 1c
Get Alerts PPHM Hot Sheet
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q4 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $9.31 million versus the consensus estimate of $6.42 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- Forian Inc. (FORA) Tops Q4 EPS by 3c, provides outlook
- CVD Equipment (CVV) Reports Q4 Loss of $0.33
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!